Results 41 to 50 of about 61,573 (234)

Current practice and guideline adherence in renal dose adjustment for patients with chronic kidney disease: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883).
Hager ElGeed   +7 more
wiley   +1 more source

Comparación del esquema antibiótico entre la Piperacilina-Tazobactam y Amikacina vs Metronidazol y Gentamicina en el tratamiento de la apendicitis complicada en niños

open access: yesRevista de la Facultad de Medicina, 2016
Introducción. Los pacientes que tuvieron complicaciones infecciosas post cirugía de apendicitis siguen usualmente un esquema de tratamiento establecido de antibióticos en el Hospital San Juan de Dios (HSJD).
José Rodrigo Sandoval   +1 more
doaj   +1 more source

The safety of ceftolozane-tazobactam for the treatment of acute bacterial infections: a systemic review and meta-analysis

open access: yesTherapeutic Advances in Drug Safety, 2021
Objective(s): The aim of this study was to conduct a meta-analysis to assess the clinical safety of ceftolozane-tazobactam for the treatment of acute bacterial infections in adult patients.
Li-Ting Wang   +7 more
doaj   +1 more source

Assessing kidney function for drug dosing in critical illness

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Kidney‐function assessment supports drug dosing in critical illness but does not directly measure drug clearance. Reduced creatinine generation, fluid shifts and rapidly changing filtration can make creatinine‐based estimates misleading, whereas genuinely augmented renal clearance can cause insufficient drug exposure. These processes can coexist.
Ming‐Shen Lin, Kuo‐Fan Liao
wiley   +1 more source

Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study

open access: yesJournal of Infection and Public Health, 2022
Background: Ceftolozane-tazobactam is an emerging ‎treatment for severe infections caused by multidrug-resistant (MDR) Pseudomonas ‎aeruginosa. However, limited ‎data support its use in bacteremia treatment.
Hakeam A. Hakeam   +10 more
doaj   +1 more source

Nephrotoxicity of concomitant piperacillin/tazobactam and teicoplanin compared with monotherapy

open access: yes, 2021
Contains fulltext : 229893.pdf (Publisher’s version ) (Open Access)OBJECTIVES: Piperacillin/tazobactam combined with vancomycin has been associated with a decline in renal function when compared with monotherapy.
Wildt, S.N. de   +11 more
core   +1 more source

Modeling Pharmacokinetics in Individual Patients Using Therapeutic Drug Monitoring and Artificial Population Quasi-Models: A Study with Piperacillin

open access: yesPharmaceutics
Population pharmacokinetic (pop-PK) models constructed for model-informed precision dosing often have limited utility due to the low number of patients recruited.
Gellért Balázs Karvaly   +6 more
doaj   +1 more source

DataSheet1_Silver(I)-Tazobactam Frameworks with Improved Antimicrobial Activity.docx

open access: yes, 2022
Tazobactam (TazoH) is a penicillinate sulfone β-lactamase inhibitor with negligible antimicrobial activity, commonly used with other antibiotics to provide an effective combination against many susceptible organisms expressing β-lactamases.
Daniela R. Ferreira (11995742)   +4 more
core   +1 more source

Incidence and impact of respiratory tract infections on outcomes in patients with status epilepticus: A 20‐year longitudinal observation

open access: yesEpilepsia, EarlyView.
Abstract Objective This study was undertaken to identify the incidence of respiratory tract infections (RTIs) in a large cohort of adult patients with status epilepticus (SE) and to characterize their associations with clinical features and outcome determinants.
Sebastian Berger   +8 more
wiley   +1 more source

Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study

open access: yesJournal of Translational Medicine, 2020
Background Extracorporeal membrane oxygenation (ECMO) is increasingly used in intensive care units and can modify drug pharmacokinetics and lead to under-exposure associated with treatment failure. Ceftolozane/tazobactam is an antibiotic combination used
Camille Mané   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy